Coronavirus Notebook: Leading Vaccines Near Approval, EU Signs More Advance Purchase Deals

Developers Are Under Pressure To Share Their IP And Reveal Costs

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".